S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
OTCMKTS:VDRM

ViaDerma (VDRM) Stock Price, News & Analysis

0.01
0.00 (-6.47%)
(As of 03/27/2024 09:04 PM ET)
Today's Range
0.01
0.01
50-Day Range
0.01
0.01
52-Week Range
0.01
0.03
Volume
379,700 shs
Average Volume
1.96 million shs
Market Capitalization
N/A
P/E Ratio
0.00
Dividend Yield
N/A
Price Target
N/A
VDRM stock logo

About ViaDerma Stock (OTCMKTS:VDRM)

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

VDRM Stock Price History

VDRM Stock News Headlines

ViaDerma, Inc. (OTCMKTS:VDRM) Sees Large Drop in Short Interest
ViaDerma Inc VDRM
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
Trending Stocks Sent To You In Real Time
Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar!
ViaDerma, Inc. Files Amended Financial Statements
ViaDerma Inc.
See More Headlines
Receive VDRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
4/17/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:VDRM
CIK
N/A
Fax
N/A
Employees
75
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Qing Hua Lin (Age 43)
    Chief Financial Officer and Director
    Comp: $4.46k
  • Mr. Baotang Zhao (Age 46)
    Chief Sales Officer
    Comp: $28.77k
  • Mr. Zhang Xie (Age 45)
    Corporate Secretary and Director
    Comp: $9.18k
  • Dr. Christopher A Otiko
    Founder, Chief Executive Officer and President
  • Dr. Andrew Berman M.D.
    MPH, Medical Director and Member of Advisory Board

VDRM Stock Analysis - Frequently Asked Questions

How have VDRM shares performed in 2024?

ViaDerma's stock was trading at 0.01 at the beginning of the year. Since then, VDRM stock has increased by 22.6% and is now trading at 0.01.
View the best growth stocks for 2024 here
.

Are investors shorting ViaDerma?

ViaDerma saw a decrease in short interest in March. As of March 15th, there was short interest totaling 4,800 shares, a decrease of 92.7% from the February 29th total of 65,800 shares. Based on an average trading volume of 2,553,200 shares, the days-to-cover ratio is presently 0.0 days.
View ViaDerma's Short Interest
.

When is ViaDerma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 17th 2024.
View our VDRM earnings forecast
.

How do I buy shares of ViaDerma?

Shares of VDRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:VDRM) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners